General MedicationsINJECTIONGeneric

LEVOFLOXACIN; DEXTROSE

Standard Dose

5% (5MG/ML)

Max Dose

Refer to approved labeling

Primary Use

Marketing status: None (Tentative Approval)

Summary

Approval overview LEVOFLOXACIN; DEXTROSE is listed in Drugs@FDA under application 090305 (ANDA).

Marketing status: None (Tentative Approval) Active ingredient LEVOFLOXACIN; DEXTROSE Form and strength INJECTABLE; INJECTION - 5% (5MG/ML) Sponsor BEDFORD LABS Submission history Latest submission status date: 2010-12-01 00:00:00.

Structured Monograph

Clinical summary

Approval overview LEVOFLOXACIN; DEXTROSE is listed in Drugs@FDA under application 090305 (ANDA). Marketing status: None (Tentative Approval) Active ingredient LEVOFLOXACIN; DEXTROSE Form and strength INJECTABLE; INJECTION - 5% (5MG/ML) Sponsor BEDFORD LABS Submission history Latest submission status date: 2010-12-01 00:00:00. Submission type: ORIG.

Monitoring

• Marketing status: None (Tentative Approval)

Interaction Notes

No interaction notes stored yet.